10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001144204-17-026492`
Period End Date	20170331
Filing Date	20170511
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	enzn-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 48 Income Statement 24 Cash Flow Statement 18

Balance Sheet 48 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$9.73M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$8.08M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$270.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$281.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$8.36M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.91M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Deferred tax assets, net	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$3.36M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Deferred tax assets, net	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$2.94M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Total assets	`Assets`	$11.30M	USD	Point-in-time
Total assets	`Assets`	$11.27M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$134.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$770.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$188.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$170.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$322.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$940.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at March 31, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at March 31, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at March 31, 2017 and December 31, 2016	`CommonStockValue`	$441.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at March 31, 2017 and December 31, 2016	`CommonStockValue`	$441.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$90.28M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$90.28M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-80.39M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-79.75M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.33M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.98M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$11.30M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$11.27M	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$1.44M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$3.22M	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	-	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$42.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$3.27M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$1.44M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$721.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$349.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$721.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$349.00K	USD	1 Quarter
Operating income and income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.09M	USD	1 Quarter
Operating income and income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.54M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$446.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.03M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.52M	USD	1 Quarter
Net income	`NetIncomeLoss`	$645.00K	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.01	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.03	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.03	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.01	USD	1 Quarter
Weighted-average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	1 Quarter
Weighted-average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	1 Quarter
Weighted-average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	1 Quarter
Weighted-average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	1 Quarter

Cash Flow Statement 18 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$1.52M	USD	1 Quarter
Net income	`NetIncomeLoss`	$645.00K	USD	1 Quarter
Deferred tax provision	`DeferredIncomeTaxExpenseBenefit`	$1.03M	USD	1 Quarter
Deferred tax provision	`DeferredIncomeTaxExpenseBenefit`	$424.00K	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$4.48M	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$629.00K	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.94M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$440.00K	USD	1 Quarter
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$440.00K	USD	1 Quarter
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.94M	USD	1 Quarter
Cash beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$9.73M	USD	Point-in-time
Cash beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Cash beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Cash beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$8.08M	USD	Point-in-time
Cash end of period	`CashAndCashEquivalentsAtCarryingValue`	$9.73M	USD	Point-in-time
Cash end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Cash end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Cash end of period	`CashAndCashEquivalentsAtCarryingValue`	$8.08M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.